Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
DMAC | DiaMedica Therapeutics Inc. | Director | $168K | Jun 1, 2024 | ||
TRIL | Trillium Therapeutics Inc. | Chief Financial Officer | Nov 17, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|